|
|
Article: Exploring the Future Trends of Schering-Plough Corp.
- Article from:
- M2 Presswire
- Article date:
- December 4, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-4 December 2006-Biotech News: Exploring the Future Trends of Schering-Plough Corp.(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:04122006
Exploring the Future Trends of Schering-Plough Corp. (NYSE:SGP)
Schering-Plough can get rid of the most embarrassing ailments -- runny noses, sunburned shoulders, and fungal feet. The druggernaut develops and markets prescription and OTC drugs, animal health products, and personal care products. Although the company is best known for its allergy medications Clarinex and Nasonex, the company specializes in anti-infectives (particularly for hepatitis) and cancer drugs. The drugmaker co-promotes erectile ...